My initial read on the company's slate of director
Post# of 148170
(Total Views: 593)
Posted On: 09/24/2021 6:12:12 PM
My initial read on the company's slate of directors is quite positive. Clearly, each one of them has more relevant, valuable experience than any member of the 13d slate. No freakin brainer.
Consider the new blood:
Seethamraju is Medical Director at a respected institute.
Ndhlovu is not yet as well known, but is a full professor. Having an MD PhD in HIV (whew!) will help guide those trials.
Urbach, the lawyer, sits on the "Executive Committee of the Oregon State Bar Securities Regulation Section," so will get that part right. She now seems to be head of advisors for a firm that manages over half a billion in "family office" money - dollars managed for generational wealth - a nice time frame for biotech.
So, I can imagine an even higher level Board, but this one brings clear competence and professional reputation in every area we need.
And, repeating, every one of them is head and shoulders above any 13d candidate.
Consider the new blood:
Seethamraju is Medical Director at a respected institute.
Ndhlovu is not yet as well known, but is a full professor. Having an MD PhD in HIV (whew!) will help guide those trials.
Urbach, the lawyer, sits on the "Executive Committee of the Oregon State Bar Securities Regulation Section," so will get that part right. She now seems to be head of advisors for a firm that manages over half a billion in "family office" money - dollars managed for generational wealth - a nice time frame for biotech.
So, I can imagine an even higher level Board, but this one brings clear competence and professional reputation in every area we need.
And, repeating, every one of them is head and shoulders above any 13d candidate.
(32)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼